SLC16A2 and Cognitive impairment: Patients exhibiting MCT8 mutations present with severe neurological symptoms including hypotonia, muscular hypoplasia, and developmental retardation [88–94] and severe cognitive impairment, a classical outcome of inappropriate myelin formation [88, 89].